Segall Bryant & Hamill’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Sell |
|
|||||
|
2025
Q1 | $9.98M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Sell |
|
|||||
|
2024
Q3 | $11.3M | Sell |
|
|||||
|
2024
Q2 | $9.43M | Sell |
|
|||||
|
2024
Q1 | $8.89M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Sell |
|
|||||
|
2023
Q3 | $14.3M | Sell |
|
|||||
|
2023
Q2 | $14.3M | Buy |
|
|||||
|
2023
Q1 | $15.3M | Buy |
|
|||||
|
2022
Q4 | $19.2M | Sell |
|
|||||
|
2022
Q3 | $21.2M | Sell |
|
|||||
|
2022
Q2 | $19.3M | Buy |
|
|||||
|
2022
Q1 | $15.3M | Buy |
|